Discover the full management transaction log of JOINT Corp, a publicly traded company based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, JOINT Corp has recorded 55 reports. Market capitalisation: €117.3m. The latest transaction was reported on 14 May 2026 — Acquisition. Among the most active insiders: KREVLIN GLENN J. The full history is openly available.
0 of 0 declarations
JOINT Corp. (ticker: JYNT) is a U.S.-based company listed on the NASDAQ in the United States. It operates in the chiropractic care segment through The Joint Chiropractic® network, combining clinic operations, management services, and franchising. For French-speaking investors, the investment case is best understood as a retail healthcare model: a consumer-facing wellness and pain-relief offering built around convenience, transparent pricing, and a simplified patient experience. The company is headquartered in Scottsdale, Arizona, and its brand proposition centers on walk-in access, no insurance complexity, and a standardized care format that differentiates it from traditional chiropractic practices. ([ir.thejoint.com](https://ir.thejoint.com/company-information?utm_source=openai)) The modern company says it acquired its predecessor in March 2010, marking the start of its current growth phase. Since then, The Joint Corp. has expanded from a small base into a nationwide platform. In its SEC filings, the company reported 967 clinics in operation at December 31, 2024, along with additional franchise licenses sold but not yet developed. Company materials also state that the network spans 43 states, with more than 14 million patient visits annually. This scale matters because the business model becomes more attractive as the network density improves and brand recognition strengthens. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1612630/000161263025000033/jynt-20241231.htm?utm_source=openai)) From a competitive standpoint, JOINT Corp. appears to be the clear scale leader in U.S. chiropractic care. Management says the brand is roughly six times larger than its nearest chiropractic chain competitor, which underscores its leading position in a still-fragmented category. The core service offering includes chiropractic adjustments, ongoing wellness care, and related patient treatment plans delivered through a standardized clinic format. The company’s recurring membership model and no-appointment approach are intended to make care more affordable and more accessible, while supporting repeat visits and a broader consumer audience. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1612630/000162828025012702/jynt-20241231.htm?utm_source=openai)) Recent developments have been focused on strategic simplification and profitability improvement. In 2024, the company continued to push toward a “pure-play franchisor” structure, refranchising certain corporate clinics and reducing direct operating exposure. In early 2025, management said it had begun executing initiatives to strengthen the core business, reignite growth, and improve both clinic-level and company-level profitability. That messaging is important for investors, as it signals a transition from a growth-at-all-costs expansion model toward a more disciplined franchise-led operating structure. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1612630/000162828025012702/jynt-20241231.htm?utm_source=openai))